MedPath

Juniper Pharmaceuticals, Inc.

πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:0
Completed:4

Trial Phases

2 Phases

Phase 2:2
Phase 3:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)β€’ Click on a phase to view related trials

Phase 2
2 (50.0%)
Phase 3
2 (50.0%)

COL-1077 (Lidocaine Bioadhesive Gel, 10%) in Women Undergoing Transvaginal Pipelle-Directed Endometrial Biopsy

Phase 2
Completed
Conditions
Endometrial Biopsy
Interventions
Drug: Placebo
First Posted Date
2015-06-08
Last Posted Date
2016-07-13
Lead Sponsor
Juniper Pharmaceuticals, Inc.
Target Recruit Count
187
Registration Number
NCT02465320
Locations
πŸ‡ΊπŸ‡Έ

Futura Research, Norwalk, California, United States

πŸ‡ΊπŸ‡Έ

Bluebird Clinical Trials, Colorado Springs, Colorado, United States

πŸ‡ΊπŸ‡Έ

Red Rocks OB/GYN, Lakewood, Colorado, United States

and more 20 locations

Efficacy and Safety Study of Lidocaine Vaginal Gel for Recurrent Dysmenorrhea (Painful Periods)

Phase 2
Completed
Conditions
Dysmenorrhea
Interventions
Drug: Placebo
First Posted Date
2008-04-02
Last Posted Date
2012-02-17
Lead Sponsor
Juniper Pharmaceuticals, Inc.
Target Recruit Count
81
Registration Number
NCT00651313
Locations
πŸ‡ΊπŸ‡Έ

Lyndhurst Gynecologic Associates, Winston-Salem, North Carolina, United States

πŸ‡ΊπŸ‡Έ

SCIREX Research Center, Austin, Texas, United States

πŸ‡ΊπŸ‡Έ

Jean Brown Research, Salt Lake City, Utah, United States

PREGNANT Short Cervix Trial

Phase 3
Completed
Conditions
Preterm Delivery
Short Cervix
Short Uterine Cervical Length
Interventions
Drug: placebo
First Posted Date
2008-02-14
Last Posted Date
2012-03-13
Lead Sponsor
Juniper Pharmaceuticals, Inc.
Target Recruit Count
465
Registration Number
NCT00615550
Locations
πŸ‡ΊπŸ‡Έ

University of South Alabama Dept. of OB/GYN, Mobile, Alabama, United States

πŸ‡ΊπŸ‡Έ

St. Joseph's Hospital and Med Ctr Women's Care Center, Phoenix, Arizona, United States

πŸ‡ΊπŸ‡Έ

UCI Medical Center, Orange, California, United States

and more 46 locations

Vaginal Progesterone to Reduce the Risk of Another Preterm Birth

Phase 3
Completed
Conditions
Pregnancy
Interventions
Drug: Placebo Vaginal Gel
First Posted Date
2004-06-29
Last Posted Date
2010-08-19
Lead Sponsor
Juniper Pharmaceuticals, Inc.
Target Recruit Count
636
Registration Number
NCT00086177
Locations
πŸ‡ΊπŸ‡Έ

University of South Alabama Department of OBGYN, Mobile, Alabama, United States

πŸ‡ΊπŸ‡Έ

Visions Clinical Research-Tucson, Tucson, Arizona, United States

πŸ‡ΊπŸ‡Έ

Women's Health Department, Colton, California, United States

and more 42 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.